REGISTER
Sign up to receive the latest information and resources about myelofibrosis
By registering at this site, you certify that you are a healthcare professional licensed in the [Affiliate Location] or its territories and wish to receive news and updates about AbbVie and its products, clinical trials, research opportunities, programs, and other information that may be of interest to you. AbbVie’s intent is to provide information to healthcare professionals licensed in the [Affiliate Location] or its territories.
For more information on AbbVie’s privacy practices, including how to opt out, visit https://www.abbviepro.com/gb/en/privacy-notice.html.
AbbVie will not sell, rent, or otherwise distribute your name or any personally identifiable information outside of AbbVie and its agents. AbbVie will use your information in accordance with its Privacy Policy.
JAK/STAT=Janus kinase signal transducer and activator of transcription; MF=myelofibrosis.
ALL-ONCMF-220048/August 2023
Our therapy areas
Additional info
This website is intended for [CountryName] Healthcare Professionals
Copyright ©2023 AbbVie Inc. North Chicago, Illinois, U.S.A.
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.